Regional microglia are transcriptionally distinct but similarly exacerbate neurodegeneration in a culture model of Parkinson’s disease
Open Access
- 11 May 2018
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 15 (1) , 139
Abstract
Parkinson’s disease (PD) is characterized by selective degeneration of dopaminergic (DA) neurons of the substantia nigra pars compacta (SN) while neighboring ventral tegmental area (VTA) DA neurons are relatively spared. Mechanisms underlying the selective protection of the VTA and susceptibility of the SN are still mostly unknown. Here, we demonstrate the importance of balance between astrocytes and microglia in the susceptibility of SN DA neurons to the PD mimetic toxin 1-methyl-4-phenylpyridinium (MPP+). Previously established methods were used to isolate astrocytes and microglia from the cortex (CTX), SN, and VTA, as well as embryonic midbrain DA neurons from the SN and VTA. The transcriptional profile of isolated microglia was examined for 21 canonical pro- and anti-inflammatory cytokines by qRT-PCR with and without MPP+ exposure. Homo- and heterotypic co-cultures of neurons and astrocytes were established, and the effect of altering the ratio of astrocytes and microglia in vitro on the susceptibility of midbrain DA neurons to the PD mimetic toxin MPP+ was investigated. We found that regionally isolated microglia (SN, VTA, CTX) exhibit basal differences in their cytokine profiles and that activation of these microglia with MPP+ results in differential cytokine upregulation. The addition of microglia to cultures of SN neurons and astrocytes was not sufficient to cause neurodegeneration; however, when challenged with MPP+, all regionally isolated microglia resulted in exacerbation of MPP+ toxicity which was alleviated by inhibition of microglial activation. Furthermore, we demonstrated that isolated VTA, but not SN, astrocytes were able to mediate protection of both SN and VTA DA neurons even in the presence of exacerbatory microglia; however, this protection could be reversed by increasing the numbers of microglia present. These results suggest that the balance of astrocytes and microglia within the midbrain is a key factor underlying the selective vulnerability of SN DA neurons seen in PD pathogenesis and that VTA astrocytes mediate protection of DA neurons which can be countered by greater numbers of deleterious microglia.Keywords
Funding Information
- The Parkinson Council
- National Institutes of Health (2 RO1 NS075839)
This publication has 64 references indexed in Scilit:
- Activation of microglia induces symptoms of Parkinson’s disease in wild-type, but not in IL-1 knockout miceJournal of Neuroinflammation, 2013
- Transfer of human α-synuclein from the olfactory bulb to interconnected brain regions in miceActa Neuropathologica, 2013
- Discovery and Validation of a New Class of Small Molecule Toll-Like Receptor 4 (TLR4) InhibitorsPLOS ONE, 2013
- Autophagic failure promotes the exocytosis and intercellular transfer of α-synucleinExperimental & Molecular Medicine, 2013
- Toll like receptor 4 mediates cell death in a mouse MPTP model of Parkinson diseaseScientific Reports, 2013
- Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-SynucleinJournal of Neuroimmune Pharmacology, 2012
- Role of Microglia in NeurotraumaNeurotherapeutics, 2010
- Microglia in ischemic brain injuryFuture Neurology, 2009
- Debris clearance by microglia: an essential link between degeneration and regenerationBrain, 2008
- Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the ratNeuroscience, 2008